Showing results (171-180 of 203) with videos related to
Sort By:
Pageof 21
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 17, 2010
Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysisJi-Young Choi, Yoo Jeong Yoon, Hee-Jeong Choi, et al.Atherosclerosis|December 19, 2017
Metabolic phenotyping of human atherosclerotic plaques: Metabolic alterations and their biological relevance in plaque-containing aortaSunhee Jung, Suk-Won Song, Sak Lee, et al.Cancer Research|January 3, 2023
Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic CancerSeung Joon Park, Hee Chan Yoo, Eunyong Ahn, et al.Kidney International|March 2, 2024
Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibitionJeonghwan Lee, Jinhaeng Lee, Kyuhong Kim, et al.Biochemical and Biophysical Research Communications|November 25, 2010
1H NMR-based metabolomic study on resistance to diet-induced obesity in AHNAK knock-out miceIl Yong Kim, Jeeyoun Jung, Mi Jang, et al.Scientific Reports|October 13, 2019
Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosisJung Nam An, Jin Seong Hyeon, Youngae Jung, et al.Kidney International|July 27, 2020
Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathyHyung Ah Jo, Jin Seong Hyeon, Seung Hee Yang, et al.Cell Death Discovery|July 10, 2026
Intrinsic polyunsaturated fatty acid synthesis capacity dictates ferroptosis sensitivity under restricted arachidonic acid availabilityMin Wook Kim, Seo Young Jang, Ji-Yoon Lee, et al.Molecular Metabolism|November 28, 2021
A novel role of CRTC2 in promoting nonalcoholic fatty liver diseaseHye-Sook Han, Sang Gyune Kim, Young Seok Kim, et al.Journal of Hepatology|April 23, 2021
Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in non-alcoholic fatty liver diseaseTaekyeong Yoo, Sae Kyung Joo, Hyo Jung Kim, et al.Pageof 21